from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3175/-

LFCtreatmentdescriptionclass of inhibitor

0.010

Amikacinug/mL Amikacintranslation

0.058

Cap5-10ug/mL Capreomycintranslation

0.037

Rox10-50 ug/mL Roxithromycintranslation

-0.240

SM2-5 ug/mL Streptomycintranslation

1.165

Tet5-10 ug/mL Tetracyclinetranslation

1.119

Rif0.2-5ug/mL Rifampicintranscription

0.551

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.524

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.716

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.198

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.343

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.602

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.780

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.041

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.878

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.965

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.512

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.236

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.183

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.346

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.222

KCN5-20 ug/mL Potassium cyaniderespiration

-0.627

NaN30.2-2 mM Sodium aziderespiration

2.486

Nigericin50 uM Nigericinrespiration

0.814

TRC10-150 ug/mL Triclosanrespiration

0.984

TRZ10-25 ug/mL Thioridazinerespiration

-0.409

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

0.375

menadione6-10 ug/mL Menadionerespiration

-0.269

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.301

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.040

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.899

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.416

NRP_1Non-replicating persistence stage 1dosRassociated

-0.098

Amp0.2mg/mL AmpicillincellWall

-0.715

Cephalexin20-100 ug/mL CephalexincellWall

1.808

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.219

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.862

EMB10-20 ug/mL EthambutolcellWall

-0.349

Eta12-40 ug/mL EthionamidecellWall

-0.698

INH0.2-0.4 ug/mL IsoniazidcellWall

0.137

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.517

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.877

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.476

BZA0.12 mg/mL BenzamidearomaticAmides

0.251

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.778

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.465

H2O24 mM hydrogen peroxideDNAdamaging

-0.225

Levo10 ug/mL LevofloxacinDNAdamaging

0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.583

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.005

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.235

UVUV-irradiationDNAdamaging

1.289

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.723

Antimycin12.5-50 ug/mL Antimycin A?

-0.717

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.260

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.247

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.455

PA8240.2-2 ug/mL PA-824?

0.045

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.487

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.118

Verapamil50 uM Verapamil?

-0.514

mercaptoethanol2 mM 2-Mercaptoethanol?

-1.563

methoxatin10-20 ug/mL Methoxatin?